Trial · NCT01308749
Adverse events48
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 48
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | # of participants with any adverse event | General disorders | Sequence 1: Oxytocin:Oxytocin Period 1weeks 0-8 | 12 | 12 | 59 |
| other | # of participants with any adverse event | General disorders | Sequence 2: Placebo: Oxytocin Period 1 Weeks 0-8 | 10 | 13 | 53 |
| other | # of participants with any adverse event | General disorders | Sequence 1: Oxytocin:Oxytocin Period 2, Weeks 8-16 | 7 | 11 | 19 |
| other | # of participants with any adverse event | General disorders | Sequence 2: Placebo:Oxytocin Period 2 | 12 | 13 | 46 |
| other | # with moderate adverse event | General disorders | Sequence 1: Oxytocin:Oxytocin Period 1weeks 0-8 | 5 | 12 | 16 |
| other | # with moderate adverse event | General disorders | Sequence 2: Placebo: Oxytocin Period 1 Weeks 0-8 | 9 | 13 | 20 |
| other | # with moderate adverse event | General disorders | Sequence 1: Oxytocin:Oxytocin Period 2, Weeks 8-16 | 3 | 11 | 5 |
| other | # with moderate adverse event | General disorders | Sequence 2: Placebo:Oxytocin Period 2 | 6 | 13 | 16 |
| other | # with severe adverse event | General disorders | Sequence 1: Oxytocin:Oxytocin Period 1weeks 0-8 | 5 | 12 | 12 |
| other | # with severe adverse event | General disorders | Sequence 2: Placebo: Oxytocin Period 1 Weeks 0-8 | 2 | 13 | 6 |
| other | # with severe adverse event | General disorders | Sequence 1: Oxytocin:Oxytocin Period 2, Weeks 8-16 | 1 | 11 | 3 |
| other | # with severe adverse event | General disorders | Sequence 2: Placebo:Oxytocin Period 2 | 1 | 13 | 5 |
| other | insomnia | Nervous system disorders | Sequence 1: Oxytocin:Oxytocin Period 1weeks 0-8 | 4 | 12 | 4 |
| other | insomnia | Nervous system disorders | Sequence 2: Placebo: Oxytocin Period 1 Weeks 0-8 | 5 | 13 | 5 |
| other | insomnia | Nervous system disorders | Sequence 1: Oxytocin:Oxytocin Period 2, Weeks 8-16 | 1 | 11 | 1 |
| other | insomnia | Nervous system disorders | Sequence 2: Placebo:Oxytocin Period 2 | 2 | 13 | 2 |
| other | Anger or irritability | Psychiatric disorders | Sequence 1: Oxytocin:Oxytocin Period 1weeks 0-8 | 1 | 12 | 1 |
| other | Anger or irritability | Psychiatric disorders | Sequence 2: Placebo: Oxytocin Period 1 Weeks 0-8 | 3 | 13 | 3 |
| other | Anger or irritability | Psychiatric disorders | Sequence 1: Oxytocin:Oxytocin Period 2, Weeks 8-16 | 1 | 11 | 1 |
| other | Anger or irritability | Psychiatric disorders | Sequence 2: Placebo:Oxytocin Period 2 | 4 | 13 | 4 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01308749/events